Drug Development/R&D
New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.
Surgical Research and Development in the NHS – Promotion, Management and Evaluation
1 July 2000
Based on papers delivered at the OHE Conference, London, 25 November 1997. Based on papers delivered at the OHE Conference, London, 25 November 1997. The UK…
Risk and Return in the Pharmaceutical Industry
1 August 1999
This book has been built up from the papers delivered at the Office of Health Economics conference which took place at the Langham Hilton Hotel, London,…
Updating the Cost of a New Chemical Entity
1 February 1999
The objective of this paper is to analyse the existing estimates of NCE costs and look at the subsequent changes in cost components and at the…
Biotechnology and the Economics of Discovery in the Pharmaceutical Industry
1 October 1998
This paper examines the economic aspects of the forces driving the emergence of biotechnology firms, and the implications of this for the organisation of research and…
Economic Evaluation and Develop Medicines in the Development of Medicines
1 April 1988
In most countries the resources available for health care are increasingly stretched in the face of the competing demands for their use. Therefore health care policy…
Crisis in Research
1 April 1986
In 1983 almost £6.6 billion was spent on research and development in the United Kingdom. This sum was five times that recorded in 1972 and even…
Pharmaceutical Innovation: Recent Trends, Future Prospects
1 October 1983
Therapeutic progress in recent decades has made a major contribution to reductions in mortality and has extended control to the symptoms of many chronic diseases. Thus…
Economic Aspects of the Development of New Medicines
1 January 1981
A lecture, on the economics of developing new drugs, particularly in relation to whether this should be a national or private enterprise. I have chosen to…
Health Research in England: Topic for Debate
1 January 1981
This paper is derived from the proceedings of an Office of Health Economics Study Day, held at the Royal College of Obstetricians and Gynaecology on 11…